Nearly half of the world’s 100 largest medical device companies saw their stock prices increase by double-digit percentages during the first 10 months of 2018, according to a Medical Design & Outsourcing analysis.
The feat is even more amazing considering that October was a rocky month for the Dow Jones Industrial Average, with the year’s gains mostly erased amid worries over Federal Reserve interest rate hikes and the U.S.-China trade war.
Medical device companies were able to buck the trend thanks to a number of different factors, including strong product launches, positive clinical trial results, new markets opening up or internal changes.
Being innovative mattered, too. It’s not too surprising that some medical device companies spending a large amount on R&D compared to revenue – including Dexcom, Abiomed, Atricure, Edwards Lifesciences and Insulet – saw their stock prices skyrocket as they marketed innovative devices in fields including diabetes management and cardiology.
Here are 10 of 2018’s top performers and a bit about what each has accomplished so far this year.
Next>>
Managing editor Chris Newmarker contributed to this report.
The post 10 of the best performing medical device stocks of 2018 appeared first on MassDevice.
from MassDevice https://ift.tt/2PIC471
Cap comentari:
Publica un comentari a l'entrada